First-in-human phase 1 clinical trial of ZM008, a monoclonal IgG1 targeting LLT1, monotherapy and in combination with pembrolizumab in advanced solid tumors
作者:
Bhattacharjee, Sanghamitra
Bhattacharjee, Sanghamitra
D O I:
10.1158/1538-7445.AM2024-7535